| David Aaron Petty, DO | |
|
3422 S 15th E, Idaho Falls, ID 83404-8262 | |
| (208) 529-9292 | |
| (208) 523-2397 |
| Full Name | David Aaron Petty |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 15 Years |
| Location | 3422 S 15th E, Idaho Falls, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376877795 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | DO0000002408 (Tennessee) | Secondary |
| 207KA0200X | Allergy & Immunology - Allergy | O-0796 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Eastern Idaho Regional Medical Center | Idaho falls, ID | Hospital |
| Mountain View Hospital | Idaho falls, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Idaho Allergy And Asthma Clinic Pa | 2860440732 | 3 |
News Archive
Under the Affordable Care Act (ACA), changes in income and family circumstances are likely to produce frequent transitions in eligibility for Medicaid and health insurance Marketplace coverage for low- and middle-income adults.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
Researchers from The University of Texas Medical Branch at Galveston have found that while the 30-day readmission rate for patients with chronic obstructive pulmonary disease has decreased, the mortality rate has increased.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the second quarter ended June 30, 2010.
NPR's "Shots" blog examines the cholera epidemic in Haiti and addresses the controversy surrounding the U.N.'s role in the outbreak, noting, "Most scientists now think Nepalese soldiers unwittingly brought cholera to Haiti when they joined a U.N. peacekeeping force there in 2010."
› Verified 6 days ago
| Entity Name | Idaho Allergy & Asthma Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003949298 PECOS PAC ID: 2860440732 Enrollment ID: O20071017000965 |
News Archive
Under the Affordable Care Act (ACA), changes in income and family circumstances are likely to produce frequent transitions in eligibility for Medicaid and health insurance Marketplace coverage for low- and middle-income adults.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
Researchers from The University of Texas Medical Branch at Galveston have found that while the 30-day readmission rate for patients with chronic obstructive pulmonary disease has decreased, the mortality rate has increased.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the second quarter ended June 30, 2010.
NPR's "Shots" blog examines the cholera epidemic in Haiti and addresses the controversy surrounding the U.N.'s role in the outbreak, noting, "Most scientists now think Nepalese soldiers unwittingly brought cholera to Haiti when they joined a U.N. peacekeeping force there in 2010."
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Aaron Petty, DO 3422 S 15th E, Idaho Falls, ID 83404-8262 Ph: (208) 529-9292 | David Aaron Petty, DO 3422 S 15th E, Idaho Falls, ID 83404-8262 Ph: (208) 529-9292 |
News Archive
Under the Affordable Care Act (ACA), changes in income and family circumstances are likely to produce frequent transitions in eligibility for Medicaid and health insurance Marketplace coverage for low- and middle-income adults.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
Researchers from The University of Texas Medical Branch at Galveston have found that while the 30-day readmission rate for patients with chronic obstructive pulmonary disease has decreased, the mortality rate has increased.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the second quarter ended June 30, 2010.
NPR's "Shots" blog examines the cholera epidemic in Haiti and addresses the controversy surrounding the U.N.'s role in the outbreak, noting, "Most scientists now think Nepalese soldiers unwittingly brought cholera to Haiti when they joined a U.N. peacekeeping force there in 2010."
› Verified 6 days ago
Dallas George Rindfleisch, DO Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3155 Channing Way Ste A, Idaho Falls, ID 83404 Phone: 208-522-6044 Fax: 208-523-4862 | |
Dr. Wendell E Petty, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3422 S 15th E, Idaho Falls, ID 83404 Phone: 208-529-9292 Fax: 208-525-6013 |